Financial Statements · Financial Reporting
AstraZeneca Eesti OÜ
Official identifier 11733875Record date 31 Dec 2023
EstoniaReport
- Legal formThe legal or organisational form recorded by the Estonian Business Register. Learn more
- OÜ
- Report status
- Registered
Dates
- Reporting year
- 2023
- Period start
- 1 Jan 2023
- Submitted date
- 28 Jun 2024
Report
- Consolidated
- No
- Audited
- Yes
Financial metrics
| Statement | Metric | Value |
|---|---|---|
| Balance sheet | Assets | 4,283,542 |
| Balance sheet | Cash and cash equivalents | 3,217,938 |
| Balance sheet | Current assets | 4,265,365 |
| Balance sheet | Current liabilities | 1,264,992 |
| Balance sheet | Equity | 3,018,550 |
| Balance sheet | Share capital at nominal value | 690,246 |
| Balance sheet | Non-current assets | 18,177 |
| Balance sheet | Retained earnings (loss) from previous periods | 1,973,017 |
| Income statement scheme 1 | Depreciation and impairment of non-current assets | -7,444 |
| Income statement scheme 1 | Labour costs | -3,608,976 |
| Income statement scheme 1 | Revenue | 5,087,993 |
| Income statement scheme 1 | Annual period profit / loss | 286,262 |
| Income statement scheme 1 | Operating profit (loss) | 286,684 |
| Income statement scheme 1 | Profit (loss) before income tax | 286,262 |
| Profit distribution proposal | Retained earnings (loss) from previous periods | 1,973,017 |
| Note: Labour costs | Employees | 37 |
| Note: Labour costs | Labour costs | 3,608,976 |
Linked company
Company: AstraZeneca Eesti OÜ